Sêmeia
PrivateLast Round
Growth Equity
May 11, 2026
Total Funding Raised
$36.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sêmeia operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Growth Equity round in May 2026.
Sêmeia is a healthtech company that develops MedicWise, a remote patient monitoring platform designed to collect and analyze health data for patients with chronic conditions to optimize care pathways.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Patient Engagement, Mental Health, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sêmeia Comparables
Compare Sêmeia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satelia | 86% | |
| Cureety | 83% | |
| Doccla | 78% |
For institutional investors. Book with your work email.
Sêmeia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 11, 2026 | ||||
| Series A | Dec 8, 2022 | ||||
| Seed | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sêmeia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Acton Capital | Growth Equity |
| Orange Ventures | Growth Equity |
| Banque des Territoires | Series A, Seed, Growth Equity |
| Citizen Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 58% MoM, reaching 23.9K.
- Jul 24, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
Sêmeia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sêmeia's valuation, stock price, and market status.
Is Sêmeia a public or private company?
Sêmeia is a private company.
What is the current stock price of Sêmeia?
Sêmeia is a private company, so its shares have no public market price. Caplight tracks Sêmeia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sêmeia worth (valuation)?
Valuation information for Sêmeia is not publicly available.
Can I buy Sêmeia stock?
Sêmeia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sêmeia's last funding round?
Sêmeia's most recent funding round was Growth Equity on May 11, 2026.
Who are the main investors in Sêmeia?
Key investors in Sêmeia include Acton Capital.
Will Sêmeia IPO soon?
No public IPO plans have been announced for Sêmeia.
How can I track Sêmeia secondary market activity?
Caplight tracks bids, offers, and trades in Sêmeia's shares on secondary markets.